A detailed history of Voya Investment Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 732,422 shares of INSM stock, worth $53.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
732,422
Previous 461,885 58.57%
Holding current value
$53.1 Million
Previous $12.5 Million 291.64%
% of portfolio
0.06%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $5.95 Million - $18.9 Million
270,537 Added 58.57%
732,422 $49.1 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $828,981 - $964,996
-32,231 Reduced 6.52%
461,885 $12.5 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $161,972 - $219,513
6,916 Added 1.42%
494,116 $15.3 Million
Q3 2023

Nov 14, 2023

SELL
$19.86 - $26.93 $478,586 - $648,959
-24,098 Reduced 4.71%
487,200 $12.3 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $1.48 Million - $1.9 Million
90,070 Added 21.38%
511,298 $10.8 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $2.22 Million - $2.96 Million
136,359 Added 47.87%
421,228 $7.18 Million
Q4 2022

Feb 14, 2023

SELL
$16.98 - $23.15 $1.06 Million - $1.45 Million
-62,718 Reduced 18.04%
284,869 $5.69 Million
Q3 2022

Mar 03, 2023

BUY
$20.88 - $28.21 $1.31 Million - $1.77 Million
62,718 Added 22.02%
347,587 $7.49 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $3.86 Million - $5.22 Million
185,100 Added 113.92%
347,587 $7.49 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $1.98 Million - $2.99 Million
116,255 Added 251.46%
162,487 $3.2 Million
Q1 2022

May 16, 2022

SELL
$20.42 - $28.13 $2.31 Million - $3.19 Million
-113,244 Reduced 71.01%
46,232 $1.09 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $3.55 Million - $4.58 Million
-136,941 Reduced 46.2%
159,476 $4.34 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $1.39 Million - $1.83 Million
-61,955 Reduced 17.29%
296,417 $8.16 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $4.75 Million - $7.08 Million
196,552 Added 121.46%
358,372 $10.2 Million
Q1 2021

May 17, 2021

SELL
$32.28 - $44.3 $642,759 - $882,101
-19,912 Reduced 10.96%
161,820 $5.51 Million
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $9.08 Million - $11.7 Million
-288,657 Reduced 61.37%
181,732 $6.05 Million
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $49,582 - $65,791
1,907 Added 0.41%
470,389 $15.1 Million
Q2 2020

Aug 14, 2020

SELL
$14.11 - $29.42 $1.03 Million - $2.14 Million
-72,840 Reduced 13.46%
468,482 $12.9 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $321,654 - $801,894
23,599 Added 4.56%
541,322 $8.68 Million
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $1.9 Million - $2.94 Million
-117,883 Reduced 18.55%
517,723 $12.4 Million
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $1.51 Million - $2.52 Million
97,566 Added 18.13%
635,606 $11.2 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $2.73 Million - $3.83 Million
118,858 Added 28.35%
538,040 $13.8 Million
Q1 2019

May 15, 2019

SELL
$13.91 - $31.15 $11.8 Million - $26.4 Million
-846,495 Reduced 66.88%
419,182 $12.2 Million
Q4 2018

Feb 14, 2019

BUY
$11.6 - $18.7 $1.19 Million - $1.92 Million
102,650 Added 8.83%
1,265,677 $16.6 Million
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $2.08 Million - $3.08 Million
109,559 Added 10.4%
1,163,027 $23.5 Million
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $5.1 Million - $7.57 Million
254,853 Added 31.91%
1,053,468 $24.9 Million
Q1 2018

May 15, 2018

BUY
$21.69 - $32.99 $2.5 Million - $3.81 Million
115,476 Added 16.9%
798,615 $18 Million
Q4 2017

Feb 14, 2018

BUY
$26.43 - $31.78 $17.1 Million - $20.6 Million
648,423 Added 1867.79%
683,139 $21.3 Million
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $403,052 - $1.08 Million
34,716
34,716 $1.08 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.82B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.